Molecule Details
InChIKeyPTJGLFIIZFVFJV-UHFFFAOYSA-N
Compound NamePyroxamide
Canonical SMILESO=C(CCCCCCC(=O)Nc1cccnc1)NO
Clinical Status Clinical Multi-Target
Targets (Human+Pathogen)12
Pfam Stratification Cross-Family
Avg pChEMBL7.37
SourceChEMBL;TTD_MultiTarget
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB12847
Drug NamePyroxamide
CAS Number382180-17-8
Groups investigational
ATC Codes nan
DescriptionPyroxamide has been used in trials studying the treatment of Leukemia, Lymphoma, Small Intestine Cancer, Precancerous Condition, and Myelodysplastic Syndromes, among others.

Categories: Amines Hydroxy Acids Hydroxylamines Pyridines
Cross-references: ChEBI: 93953 CHEMBL353581 ChemSpider: 4822 PubChem:4996 PubChem:347829008 ZINC: ZINC000003820709
Target Activities (12)
Target Gene Organism Category Pfam pChEMBL Type Source
Q13547 HDAC1 Homo sapiens Human PF00850 8.6 pIC50 TTD_MultiTarget
P56524 HDAC4 Homo sapiens Human PF12203 PF00850 8.3 pIC50 TTD_MultiTarget
Q02161 RHD Homo sapiens Human PF00909 8.3 pIC50 TTD_MultiTarget
Q92769 HDAC2 Homo sapiens Human PF00850 8.3 pIC50 TTD_MultiTarget
Q9UBN7 HDAC6 Homo sapiens Human PF00850 PF02148 7.7 IC50 ChEMBL
O15379 HDAC3 Homo sapiens Human PF00850 7.4 IC50 ChEMBL
Q8WUI4 HDAC7 Homo sapiens Human PF00850 6.7 IC50 ChEMBL
Q969S8 HDAC10 Homo sapiens Human PF00850 6.7 IC50 ChEMBL
Q96DB2 HDAC11 Homo sapiens Human PF00850 6.7 IC50 ChEMBL
Q9UKV0 HDAC9 Homo sapiens Human PF12203 PF00850 6.7 IC50 ChEMBL
Q9UQL6 HDAC5 Homo sapiens Human PF12203 PF00850 6.7 IC50 ChEMBL
Q9BY41 HDAC8 Homo sapiens Human PF00850 6.3 IC50 ChEMBL
DrugBank Target Actions (1)
Target Gene Target Name Action Type
Q13547 HDAC1 Histone deacetylase 1 inhibitor targets